Alfredo Tomy
liked
$Arbe Robotics (ARBE.US)$
Arbe Collaborates with NVIDIA to Enhance Radar-Based Free Space Mapping and AI-Driven Capabilities
Monday, 6th January at 8:00 am
Arbe to Showcase How Rich, Ultra-High-Definition Perception Radar Transforms Vehicle Safety and Autonomy at CES 2025
TEL AVIV, Israel, Jan. 6, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE), a global leader in Perception Radar solutions, announced today that in collaboration with NVIDIA, Arbe is enhancing free space ma...
Arbe Collaborates with NVIDIA to Enhance Radar-Based Free Space Mapping and AI-Driven Capabilities
Monday, 6th January at 8:00 am
Arbe to Showcase How Rich, Ultra-High-Definition Perception Radar Transforms Vehicle Safety and Autonomy at CES 2025
TEL AVIV, Israel, Jan. 6, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE), a global leader in Perception Radar solutions, announced today that in collaboration with NVIDIA, Arbe is enhancing free space ma...
7
1
Alfredo Tomy
liked
$Paltalk (PALT.US)$
Sample of high reward was BNOX to NEUP
Sample of stock plummeting was MARX to STAI this week.
Sample of high reward was BNOX to NEUP
Sample of stock plummeting was MARX to STAI this week.
4
2
1
Alfredo Tomy
commented on
$Cerence (CRNC.US)$ 🦸♂️🦸♂️🚀🚀🥃🥃
1
1
Alfredo Tomy
commented on
$Cerence (CRNC.US)$ gonna hit 20 today
2
Alfredo Tomy
liked
$Curis (CRIS.US)$
Combination therapies for the treatment of cancer
Patent number: 12178821
Abstract: The present disclosure relates to methods of treating certain diseases and disorders (e.g., cancer) with a combination of an IRAK4 inhibitor, a BCL-2 inhibitor, and a nucleoside analog.
Type: Grant
Filed: February 25, 2022
Date of Patent: December 31, 2024
Assignee: Curis, Inc.
Inventors: Reinhard von Roemeling, Andrey Ugolkov, Robert Martell
Combination therapies for the treatment of cancer
Patent number: 12178821
Abstract: The present disclosure relates to methods of treating certain diseases and disorders (e.g., cancer) with a combination of an IRAK4 inhibitor, a BCL-2 inhibitor, and a nucleoside analog.
Type: Grant
Filed: February 25, 2022
Date of Patent: December 31, 2024
Assignee: Curis, Inc.
Inventors: Reinhard von Roemeling, Andrey Ugolkov, Robert Martell
14
9
Alfredo Tomy
reacted to
$Curis (CRIS.US)$
Run it Champ 💪
Run it Champ 💪
4